In fact, our data necessitate a closer examination of the pretreatment baseline levels of Th1 class and Th2 class cytokines in patients scheduled for IFN-α therapy, as interferon-induced depression may in fact involve a pre-existing imbalance in the host Th1/Th2 levels, rendering certain patients vulnerable to depression. The gene discussed is IFNA1; the disease is major depressive disorder.